Back to Search Start Over

Use of dexmedetomidine in complex treatment of patients in intensive care units

Authors :
Dmytro Dmytriiev
Oleksandr Nazarchuk
Yuliana Babina
Source :
Perioperative Medicine, Vol 5, Iss 1 (2022)
Publication Year :
2022
Publisher :
Interdisciplinary Academy of Pain Medicine, 2022.

Abstract

Sedation is an important aspect of adequate treatment of patients in the intensive care unit. Recent drug developments and new ventilation strategies provide improved sedation management that allows for better adaptation to the clinical condition and individual needs of the patient. This article provides an overview of the general principles of sedation of patients in intensive care units and focuses on a relatively new drug in the pharmaceutical market of Ukraine — dexmedetomidine. Given the pandemic of coronavirus disease COVID-19, there was carried out a review of the international and domestic literature describing the use of dexmedetomidine as a sedative and analgesic in patients with acute respiratory distress syndrome caused by SARS-COV-2 virus. Its anti-inflammatory and antioxidant properties are also described, which will allow the use of the drug in complex therapy in the treatment of COVID-19 in severe patients.

Details

Language :
Russian, Ukrainian
ISSN :
2616339X and 26172925
Volume :
5
Issue :
1
Database :
Directory of Open Access Journals
Journal :
Perioperative Medicine
Publication Type :
Academic Journal
Accession number :
edsdoj.6fe8c0a477b2456d85437c0b9a4da6be
Document Type :
article
Full Text :
https://doi.org/10.31636/prmd.v5i1.1